{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-011587","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2024-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.377496+00:00","generated_at":"2026-06-06T05:18:33.101028+00:00","sec_items":["1.01","3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"China Pharma subsidiary acquires psoriasis patent for $1.5M in stock","bullets":["Helpson, a wholly owned subsidiary of China Pharma, entered a Technology Transfer Agreement with Lihua Li to acquire an invention patent for a psoriasis treatment.","Total consideration is $1.5 million, paid via 15 million restricted shares of common stock at $0.10 per share to the transferor and two designees.","If the product launches and generates profit within 10 years, Helpson will pay 10% of annual net profit in cash to the transferor.","Shares will be issued in an offshore transaction exempt from registration under Regulation S of the Securities Act."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-011587","json":"https://secwatch.observer/filing/0001213900-24-011587.json","markdown":"https://secwatch.observer/filing/0001213900-24-011587.md","text":"https://secwatch.observer/filing/0001213900-24-011587.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024011587/0001213900-24-011587-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024011587/ea193188-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T05:18:33.101028+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8d5440d706531919b4981bdd08eb0b2c9edc669e","claim":"CHINA PHARMA HOLDINGS, INC. entered into Technology Transfer Agreement with Lihua Li valued at $1.50 million (effective 2024-02-02).","evidence_excerpt":"ntered into a Technology Transfer Agreement (the “ Agreement ”) with Lihua Li (the “ Transferor ”). The Transferor owns an invention patent of a pharmaceutical composition for treatment of psoriasis (the “ Invention Patent ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1106644/000121390024011587/0001213900-24-011587-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"license"},{"label":"Counterparty","value":"Lihua Li"},{"label":"Value","value":"$1.50 million"},{"label":"Effective","value":"2024-02-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}